Company news

Sun Pharma Advanced Research Co. Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Press Release Apr 30 2026

April 29, 2026

Press Release Feb 03 2026

February 3, 2026

Sun Pharma Advanced Research Co. Ltd. Press Release Feb 03 2026

February 2, 2026

Press Release Dec 31 2025

December 31, 2025

Press Release Dec 02 2025

December 2, 2025

Press Release Nov 20 2025

November 20, 2025

Press Release Mar 31 2025

March 31, 2025

Sun Pharma Advanced Research Co. Ltd. Press Release Mar 31 2025

March 30, 2025

Press Release Dec 17 2024

December 17, 2024

Sun Pharma Advanced Research Co. Ltd. Press Release Dec 17 2024

December 16, 2024

Press Release Dec 14 2024

December 14, 2024

Sun Pharma Advanced Research Co. Ltd. Press Release Dec 14 2024

December 13, 2024

Press Release Apr 10 2024

April 10, 2024

Sun Pharma Advanced Research Co. Ltd. Press Release Apr 10 2024

April 9, 2024

Press Release Jan 04 2024

January 4, 2024

Press Release Nov 02 2023

November 2, 2023

Sun Pharma Advanced Research Co. Ltd. Press Release Nov 02 2023

November 1, 2023

Press Release Oct 30 2023

October 30, 2023

Sun Pharma Advanced Research Co. Ltd. Press Release Oct 30 2023

October 29, 2023

Press Release Oct 19 2023

October 19, 2023

AGM Speech 2022-23

August 7, 2023

Press Release Jul 13 2023

July 13, 2023

Press Release Nov 18 2022

November 18, 2022

SEZABY™ (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures

November 17, 2022

Press Release Nov 09 2022

November 9, 2022

Outcome of committee meeting

November 8, 2022

Press Release Sep 29 2022

September 29, 2022

AGM Speech 2021-22

September 22, 2022

FY 2021-22

August 30, 2022

Corporate Presentation

July 8, 2022

Press Release (Revised) Dec 10 2021

December 10, 2021

Press Release Dec 10 2021

December 10, 2021

Update on SPARC strategy and portfolio

December 9, 2021

Press Release Dec 08 2021

December 8, 2021

SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma

December 7, 2021

Press Release Dec 03 2021

December 3, 2021

Press Release Nov 26 2021

November 26, 2021

AGM Speech 2020-21

September 30, 2021

Press Release May 14 2021

May 14, 2021

Press Release Oct 14 2020

October 14, 2020

Press Release Sep 22 2020

September 22, 2020

Press Release (Revised) Aug 19 2020

August 19, 2020

Press Release Aug 19 2020

August 19, 2020

Press Release Sun Pharma and SPARC enter into a worldwide license agreement for SCD 044May 28, 2020

May 29, 2020

Sun Pharma Advanced Research and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension

September 14, 2018

Decks

The 5 newest of 26 decks. Every deck is listed under its year.